Biotechnology News

June 5, 2012

BERLIN--(BUSINESS WIRE)--Crescendo Bioscience®, Inc., a molecular diagnostics company, today announced data indicating that the Company’s multi-biomarker blood test, Vectra™ DA, may help identify patients in remission.

June 5, 2012

AIX-EN-PROVENCE, France--(BUSINESS WIRE)--SuperSonic Imagine, the innovative ultrasound imaging company names Kurt Kelln Executive VP of Sales and Marketing and Chief Business Officer. He will direct key strategic & commercial partnerships...

June 5, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) announced today that its 2012 Analyst Day will be webcast live on Tuesday, June 12, 2012 at 10:00 a.m. ET. To access the live webcast, please visit Biogen Idec’s Investor Relations...

June 5, 2012

SÃO PAULO--(BUSINESS WIRE)--Today, GE Healthcare announced the acquisition of XPRO, a Brazilian Interventional X-ray equipment manufacturer company.

June 5, 2012

WASHINGTON--(BUSINESS WIRE)--The 2012 BIO International Convention will return to Boston, Mass. for the global event for biotechnology, which will take place June 18-21, 2012 at the Boston Convention and Exhibition Center.

June 5, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences, Inc. today announced an initial agreement to partner with Rubicon Genomics in a reagent supply and collaboration program. The collaboration will integrate enrichment methods for...

June 5, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced that it has received a $15.8 million payment from Bayer Consumer Care AG (Bayer) under the terms of their August 2010 collaboration arrangement to develop...

June 5, 2012

FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx, a leader in innovative cell-based assays for GPCRs, Kinases, NHRs and Proteases, today unveiled a break-through technology called InCELL Hunter™. This platform marks a significant step forward as...

June 5, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today reported positive updated interim data from an ongoing phase 2 trial of cabozantinib in men with metastatic castration-resistant prostate cancer (CRPC) and bone...

June 5, 2012

FARMINGTON, Conn.--(BUSINESS WIRE)--Online learning symposium about laparoscopic liver surgery and pancreatic surgery.

June 5, 2012

WILLOW GROVE, Pa.--(BUSINESS WIRE)--Bill Anderson, pioneer of postmortem toxicology joins NMS Labs

June 5, 2012

LONDON--(BUSINESS WIRE)--New market report "MRI Market in India 2012" elaborated by Netscribes has been recently published by Market Publishers Ltd.

June 5, 2012

INGELHEIM, Germany and INDIANAPOLIS, US--(BUSINESS WIRE)--EX US & UK. Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) are pleased to announce that less than two years after forming a strategic alliance aimed at bringing new...

June 5, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at the William Blair & Company 32nd Annual Growth Stock...

June 5, 2012

ANKARA, Turkey--(BUSINESS WIRE)--At the 7th National Molecular and Diagnostic Microbiology Congress in Ankara, Bruker announces an exclusive framework agreement with Düzen (www.duzen.com....

June 5, 2012

BOSTON & GENEVA--(BUSINESS WIRE)--Global ePRO innovator PHT Corp.'s founder Dr. Stephen Raymond and Europe GM Valdo Arnera MD will discuss advances in eClinical research technology at DIA Conference June 24-17, Philadelphia.

June 5, 2012

VAN NUYS, Calif.--(BUSINESS WIRE)--ITT Exelis and Altapure, LLC are launching a new model of their state-of-the-art disinfection system.

June 5, 2012

CHICAGO--(BUSINESS WIRE)--bioTheranostics announced study results showing that its CancerTYPE ID® molecular test helped guide chemotherapy and improve survival for patients with carcinoma of unknown primary site (CUP).

June 5, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, according to interviewed payers in the EU5 (France, Germany, Italy, Spain and the...

June 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dr. Stephen Quake, one of the world’s most prolific inventors, was announced today as recipient of the 2012 $500,000 Lemelson-MIT Prize.

June 5, 2012

MALVERN, Pa.--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has raised a total of...

June 5, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Bio Nebraska Life Sciences Association , has launched a new career center for its members who are recruiting or seeking career opportunities within the science and technology fields.

June 5, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today announced the commercial launch of its ICE COLD-PCR mutation detection technology, a breakthrough technology enabling unmatched sensitivity and complete DNA mutation detection...

June 5, 2012

MALVERN, Pa.--(BUSINESS WIRE)--Ceptaris Therapeutics, Inc., a privately held specialty pharmaceutical company, announced today that it has raised $10 million through a Series D-1 private placement of preferred stock.

June 5, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will host a live webcast in conjunction with its Investor Day on Monday, June 11, 2012 at 8:30 a.m. EDT at NASDAQ. In this Investor Day, members of Cubist management...

June 5, 2012

BOULDER, Colo.--(BUSINESS WIRE)--BIO Panel on personalized Medicine to include Biodesix VP, Paul Beresford

June 5, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) has granted exclusive distribution rights to taiba ME (taiba) for the use of Kalbitor in the treatment of hereditary angioedema (HAE) within the Middle East, including Saudi Arabia,...

June 5, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Celator® Pharmaceuticals Announces Presentations of Positive Survival Analyses from CPX-351 Studies at ASCO Annual Meeting

June 5, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals announces promising clinical data for ZEVALIN® (ibritumomab tiuxetan) Injection for intravenous use and for belinostat at American Society of Clinical Oncology (ASCO) Meeting.

June 5, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx announced that two Notices of Allowance have been issued by the United States Patent and Trademark Office(USPTO)for BL-1021, an orally available small molecule for treating neuropathic pain.

June 5, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: The Board of directors of DiaGenic ASA (the “Company”) hereby summons for the annual general meeting. Time:   26 June 2012 at 13:00 hours (CET) Place:   Grenseveien 92, Oslo, Norway Agenda: 1....

June 5, 2012

LYON, France & PHILADELPHIA--(BUSINESS WIRE)--ERYTECH Pharma, a late-stage French biopharmaceutical company developing medicinal products for oncology, is pleased to announce that it received a total of € 6.95 million in support from the...

June 5, 2012

PARIS--(BUSINESS WIRE)--Exonhit receives € 1.93 million from OSEO (French Agency for funding of innovation) within a personalized medicine project in cancer.

June 5, 2012

MELBOURNE, Australia--(BUSINESS WIRE)--Former Senior Director of Worldwide Business Development at Pfizer Inc, Dr Paul Resnick, has joined Australian biotechnology company Agenix (ASX: AGX).

June 4, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., (NYSE:PKI) a global leader focused on improving the health and safety of people and the environment, announced today that on Thursday, June 7, 2012, Kevin Hrusovsky, President, Life Sciences and...

June 4, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today that it has promoted Vincent J. Angotti to the newly created role of Executive Vice President, Chief Operating Officer, with responsibilities for commercialization...

June 4, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Promising data from a Phase 2 study comparing the efficacy of selumetinib (AZD6244/ARRY-886) in combination with docetaxel versus docetaxel alone in KRAS mutant NSCLC was presented at ASCO.

June 4, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Promising data on MEK162 in an ongoing Phase 2 trial of patients with BRAF and NRAS mutated advanced melanoma was presented today at the ASCO Annual Meeting.

June 4, 2012

SAN DIEGO--(BUSINESS WIRE)--Amylin Pharmaceuticals (Nasdaq:AMLN) to present data and host investor presentation at American Diabetes Association June 8-12, 2012 in Philadelphia, PA.

June 4, 2012

CHICAGO--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) presented preliminary results today from the ongoing Phase I clinical trial for its oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB024360, at the American Society of Clinical...

June 4, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Meta-analysis of Navidea Biopharmaceuticals Lymphoseek® Phase 3 Data Compared to Standard of Care Techniques Published in Conjunction with the ASCO Annual Meeting

June 4, 2012

CHICAGO--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that analyses from several clinical studies of Jakafi® (ruxolitinib) were presented at the 2012 American Society of Clinical Oncology Annual Meeting from June 1 to 5....

June 4, 2012

NEW ORLEANS--(BUSINESS WIRE)--MiniVax, Inc. (MiniVax), a company focused on the development of novel treatments for opportunistic bacterial and fungal infections, recently announced an update on the progress of its Pneumocystis (PC) vaccine...

June 4, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today announced results from a study of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)...

June 4, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today reported data from the phase 3 pivotal trial of cabozantinib in patients with progressive, unresectable, locally advanced or metastatic medullary thyroid cancer (MTC...

June 4, 2012

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc. (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that its common stock began trading on the quality-...

June 4, 2012

SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc., today announced preliminary clinical findings from two ongoing, open-label phase 2 studies demonstrating that FG-4592, its investigational oral hypoxia-inducible factor (HIF) prolyl hydroxylase...

June 4, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--Affymetrix, Illumina & Life Technologies Hold Entrenched Leadership Positions in Key Gene Expression Profiling Market Segments. Healthy Growth Projected.